Giuseppe Cicero

Targeting Human γδ T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer

Francesco Dieli, David Vermijlen, Fabio Fulfaro et al. · Cancer Research · 2007 · 480 citations · Full text

Medicine, Immunology, Oncology +16

<i>In vivo</i> manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

Serena Meraviglia, Matthias Eberl, David Vermijlen et al. · Clinical & Experimental Immunology · 2010 · 289 citations · Full text

Medicine, Immunology, Oncology +17

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Daniele Santini, Bruno Vincenzi, Raffaele Addeo et al. · Annals of Oncology · 2012 · 213 citations · Full text

Medicine, Oncology, Pharmacology +12

Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer

Serena Meraviglia, Elena Lo Presti, Marie Tosolini et al. · OncoImmunology · 2017 · 170 citations · Full text

Life Sciences, Immunology, Oncology +17

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Francesco Passiglia, Giuseppe Bronte, Viviana Bazan et al. · Oncotarget · 2016 · 166 citations · Full text

Medicine, Cancer Biology, Oncology +17